Molecular Characteristics of High-Dose Melphalan Associated Oral Mucositis in Patients with Multiple Myeloma: A Gene Expression Study on Human Mucosa

Mette Marcussen(Aalborg University), Hans Erik Johnsen(Herlev Hospital), Heidi S. Christensen(Aalborg University Hospital), Mogens Vyberg(Aalborg University Hospital), Julie Støve Bødker(Chr. Hansen (Denmark)), Martin Bøgsted(Chr. Hansen (Denmark)), Preben Johansen(Chr. Hansen (Denmark)), Olav J. Bergmann(Hospital South West Jutland), Karen Dybkær(Aalborg University Hospital), Søren Nielsen(Aalborg University Hospital), Ilse Christiansen(Aalborg University Hospital)

PLoS ONE

January 4, 2017

10.1371/journal.pone.0169286

Cited by 12

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder

|Journal of Medicinal Chemistry|2011|602

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|396

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

|Blood|2009|390

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Leukemia|2012|362